AreasFocus, starting, and ADHDMedication and how it works

Five minutesAny ordinary dayMedical and treatmentFocus, starting, and ADHD

The potential for misuse belongs to one of the three families rather than to ADHD medicines generally. The stimulants reach the reward circuitry and the others do not.

That gives a clear answer where there is a substance history in the house, or a worry about tablets going missing at school. Say plainly that a non-stimulant is a real option rather than a consolation prize, and say just as plainly that stimulants generally do more for the core symptoms. Both facts belong in the same conversation.

Before you use this

This explains how treatments work. Never start, stop or change a medication because of something you read here.

Qur’an and Sunnah

'weigh with accurate scales: that is better and fairer in the end' (Quran 17:35). Weighing a real risk accurately is a different thing from refusing a whole class of medicine because of it.

وَأَوۡفُواْ ٱلۡكَيۡلَ إِذَا كِلۡتُمۡ وَزِنُواْ بِٱلۡقِسۡطَاسِ ٱلۡمُسۡتَقِيمِۚ ذَٰلِكَ خَيۡرࣱ وَأَحۡسَنُ تَأۡوِيلࣰ ا

Give full measure when you measure, and weigh with accurate scales: that is better and fairer in the end

Qur’an 17:35read it in the library

Translation: M.A.S. Abdel Haleem, The Qur'an, Oxford University Press, 2004.

What the research says

A follow-up using data from a large randomised trial, with methods designed to handle confounding, found stimulant treatment was not associated with more substance use later on. That concerns treated patients rather than diversion or misuse by other people. So the difference between classes stays a fair basis for choosing when there is risk in the household, while the fear about the patient's own future use has been tested and not supported.

Molina BSG, Kennedy TM, Howard AL, Swanson JM, Arnold LE, Mitchell JT, Stehli A, Kennedy EH, Epstein JN, Hechtman LT, Hinshaw SP, Vitiello B. (2023). Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.. JAMA psychiatry doi

Strength of evidence: one line of research. A single study, or a theoretical account.

Why it works

The risk of misuse follows the pathway a drug reaches, so drugs that avoid it carry less.

This one is still a draft. It is waiting on a scholar and a clinician to read it before it is published.

Near this one

More on focus, starting, and adhd

The potential for misuse belongs to one of the three families rather than to ADHD medicines generally. The stimulants reach the reward circuitry and the others do not · Inshirah